Antifungal quinazolinones from marine-derived Bacillus cereus and their preparation

Bioorganic and Medicinal Chemistry Letters

Volumn 21, Issue 13, 2011, Pages 4005-4007

  Xu, Zhihong ^a   Zhang, Yapeng ^a   Fu, Haichao ^c   Zhong, Huimin ^c   Hong, Kui ^b   Zhu, Weiming ^a  

^a OCEAN UNIVERSITY OF CHINA   (China)

^b WUHAN UNIVERSITY   (China)

^c QINGDAO UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Antifungal activity; Bacillus cereus; Chemical synthesis; Microbial metabolites; New quinazolinones alkaloids

Indexed keywords

2 (HEPTAN 3 YL) 2,3 DIHYDROQUINAZOLIN 4(1H) ONE; 2 (HEPTAN 3 YL)QUINAZOLIN 4(3H) ONE; 2 BENZYLQUINAZOLIN 4(3H) ONE; 2 METHYLQUINAZOLIN 4(3H) ONE; ALCOHOL; QUINAZOLINONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; BACILLUS CEREUS; CANDIDA ALBICANS; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL BOND; CONTROLLED STUDY; DRUG ISOLATION; DRUG SYNTHESIS; ISOMER; MARINE SPECIES; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RACEMIZATION; SPECTROSCOPY;

ANTIFUNGAL AGENTS; AQUATIC ORGANISMS; BACILLUS CEREUS; CANDIDA ALBICANS; MAGNETIC RESONANCE SPECTROSCOPY; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; QUINAZOLINONES;

BACILLUS CEREUS; BACTERIA (MICROORGANISMS); CANDIDA ALBICANS;

EID: 79958727587     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2011.05.002     Document Type: Article

References (20)

1. Richardson, M. D. J. Antimicrob. Chemother. 1991, 28, 1.
2. Morschhauser, J. Fungal Genet. Biol. 2010, 47, 94.
3. Chakrabarty, M.; Batabyal, A.; Morales-Ríos, M. S.; Joseph-Nathan, P. Monatsh. Chem. 1995, 126, 789.
4. Fdhila, F.; Vázquez, V.; Sánchez, J. L.; Riguera, R. J. Nat. Prod. 2003, 66, 1299.
5. Adamczeski, M.; Reed, A. R.; Crews, P. J. Nat. Prod. 1995, 58, 201.
6. Wang, Y. C.; Zhou, J.; Tan, N. H.; Ding, Z. T.; Jiang, X. Acta Pharm. Sin. 1999, 34, 19.
7. Xiong, J.; Zhou, J.; Dai, H. F.; Tan, N. H.; Ding, Z. T. Acta Bot. Yunnan 2002, 24, 401.
8. 3) see Table 1.
9. Zhang, D. T.; Tang, L. D.; Duan, G. Y.; Zhao, G. L.; Xu, W. R.; Meng, L. J.; Wang, J. W. Chem. Res. Chin. U. 2006, 22, 584.
10. Miura, M.; Toriyama, M.; Motohashi, S. Synth. Commun. 2006, 36, 259.
11. +, 285.1 [M+Na].
12. Kshirsagar, U. A.; Mhaske, S. B.; Argade, N. P. Tetrahedron Lett. 2007, 48, 3243.
13. D20 +0.4 (c 1, acetone); NMR data were consistent to the natural.
14. 20 -1.1 (c 1.0, acetone); NMR data was consistent t.
15. +.
16. +.
17. 2 to give 7 as a white crystal (95 mg, 85% yield). NMR data was consistent to 1.
18. 4 (32 mg, 0.82 mmol) to give 8 as a white powder (9.6 mg, 48% yield).
19. Zaika, L. L. J. Food Safety 1988, 9, 97.
20. 19 The tested strain, C. albicans, was cultivated in in YPD agar plates at 37 °C. Compounds 1-8 and ketoconazole (positive control) were dissolved in methanol at different concentrations from 10 to 0.078 μg/mL by the continuous two-fold dilution methods. A 10 μL quantity of test solution was absorbed by a paper disc (5 mm diameter) and placed on the assay plates. After 12 h incubation, zones of inhibition (mm in diameter) were recorded. The minimum inhibitory concentrations (MICs) were defined as the lowest concentration at which no microbial growth could be observed. The MIC values of compounds 1-8 were 2.5, 2.5, 15.6, 10.6, 1.3, 5.0, 10.2, and 10.1 μM, respectively (ketoconazole with MIC value of 0.2 μM).